| Drug Name | Hydroxychloroquine |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Safety communication
|
| Specialty (Theraputic area) |
Infectious disease
|
| Risk |
SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19
Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems
|
| safety communication |
|